IL229126A0 - process - Google Patents

process

Info

Publication number
IL229126A0
IL229126A0 IL229126A IL22912613A IL229126A0 IL 229126 A0 IL229126 A0 IL 229126A0 IL 229126 A IL229126 A IL 229126A IL 22912613 A IL22912613 A IL 22912613A IL 229126 A0 IL229126 A0 IL 229126A0
Authority
IL
Israel
Application number
IL229126A
Other languages
English (en)
Hebrew (he)
Original Assignee
Astrazeneca Ab
Barnwell Neil
Keefe Philip O
Cornwall Philip
Howell Gareth P
Meadows Rebecca Elizabeth
Merifield Eric
Mitchell Christopher William
Murugan Andiappan
Patel Zakariya Mohamed
Singleton John
Withnall Jane
Gili Duncan Michael
Rose James Barry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab, Barnwell Neil, Keefe Philip O, Cornwall Philip, Howell Gareth P, Meadows Rebecca Elizabeth, Merifield Eric, Mitchell Christopher William, Murugan Andiappan, Patel Zakariya Mohamed, Singleton John, Withnall Jane, Gili Duncan Michael, Rose James Barry filed Critical Astrazeneca Ab
Publication of IL229126A0 publication Critical patent/IL229126A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/07—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton
    • C07C309/08—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/24—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/06—Oxalic acid
    • C07C55/07—Salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL229126A 2011-05-13 2013-10-28 process IL229126A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1107985.2A GB201107985D0 (en) 2011-05-13 2011-05-13 Process
PCT/GB2012/051037 WO2012156693A1 (en) 2011-05-13 2012-05-11 Process

Publications (1)

Publication Number Publication Date
IL229126A0 true IL229126A0 (en) 2013-12-31

Family

ID=44260448

Family Applications (1)

Application Number Title Priority Date Filing Date
IL229126A IL229126A0 (en) 2011-05-13 2013-10-28 process

Country Status (14)

Country Link
US (2) US20140364601A1 (enExample)
EP (1) EP2707362A1 (enExample)
JP (1) JP2014520075A (enExample)
KR (1) KR20140045380A (enExample)
CN (1) CN103649060A (enExample)
AU (1) AU2012257630A1 (enExample)
BR (1) BR112013028789A2 (enExample)
CA (1) CA2835237A1 (enExample)
GB (1) GB201107985D0 (enExample)
IL (1) IL229126A0 (enExample)
MX (1) MX2013012484A (enExample)
RU (1) RU2013148907A (enExample)
SG (1) SG194631A1 (enExample)
WO (1) WO2012156693A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3192B1 (ar) 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون
CN103193658A (zh) * 2013-04-18 2013-07-10 苏州永健生物医药有限公司 一种（r）-2-对硝基苯乙胺基-1-苯乙醇及其盐的合成方法
TWI685497B (zh) 2014-06-02 2020-02-21 西班牙商伊史帝夫製藥公司 具有多重模式抗疼痛活性的１-氧雜-４,９-二氮雜螺十一烷化合物之烷基衍生物
TW201615642A (zh) * 2014-06-02 2016-05-01 伊史帝夫博士實驗室股份有限公司 具有多重模式抗疼痛活性的１－氧雜－４，９－二氮雜螺十一烷化合物之醯胺衍生物
CN108349999A (zh) 2015-11-16 2018-07-31 埃斯蒂文博士实验室股份有限公司 用于治疗药物滥用和成瘾的氧杂二氮杂螺环化合物
CN111263764A (zh) 2017-10-17 2020-06-09 埃斯蒂文制药股份有限公司 (r)-9-(2,5-二氟苯乙基)-4-乙基-2-甲基-1-氧杂-4,9-二氮杂螺[5.5]十一烷-3-酮的盐

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1058683B1 (en) 1998-02-02 2002-12-04 Lg Chemical Limited Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof
AR040962A1 (es) 2002-08-09 2005-04-27 Novartis Ag Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
GB0218629D0 (en) * 2002-08-09 2002-09-18 Novartis Ag Organic compounds
CN101300239A (zh) * 2005-08-29 2008-11-05 阿斯利康(瑞典)有限公司 作为β2肾上腺素受体激动剂的7-（2-氨基-1-羟基-乙基）-4-羟基苯并噻唑-2(3H)-酮衍生物
TW200738659A (en) * 2005-08-29 2007-10-16 Astrazeneca Ab Novel compounds
EA018711B1 (ru) 2008-02-06 2013-10-30 Астразенека Аб Производные диазаспиро[5.5]ундекана в качестве антагонистов мускариновых рецепторов и агонистов бета-адренорецепторов для применения в лечении легочных расстройств

Also Published As

Publication number Publication date
JP2014520075A (ja) 2014-08-21
CA2835237A1 (en) 2012-11-22
GB201107985D0 (en) 2011-06-29
KR20140045380A (ko) 2014-04-16
EP2707362A1 (en) 2014-03-19
WO2012156693A1 (en) 2012-11-22
AU2012257630A1 (en) 2013-11-28
SG194631A1 (en) 2013-12-30
BR112013028789A2 (pt) 2016-08-09
US20160002261A1 (en) 2016-01-07
MX2013012484A (es) 2014-01-24
RU2013148907A (ru) 2015-06-20
CN103649060A (zh) 2014-03-19
US20140364601A1 (en) 2014-12-11

Similar Documents

Publication Publication Date Title
GB201121308D0 (en) Process
GB201103499D0 (en) Process
GB201111595D0 (en) Improved process
GB201107072D0 (en) Process
PL2793599T3 (pl) Sposób
GB201218123D0 (en) Process
ZA201305221B (en) Process
GB201121557D0 (en) Process
GB201112051D0 (en) Process
GB201107073D0 (en) Process
IL229126A0 (en) process
GB201115218D0 (en) Novel process
GB201218121D0 (en) Process
GB201218124D0 (en) Process
PT2726454T (pt) Processo
GB201112370D0 (en) Process
GB201103092D0 (en) Process
GB201107221D0 (en) Process
GB201105537D0 (en) New process
SG11201403684YA (en) Process
GB2493491B (en) Process
GB201208567D0 (en) Process
GB201108531D0 (en) Process
GB201117039D0 (en) Process
GB201104762D0 (en) Process